IP Library Granted Patent US 8,390,455
Granted Patent B2
US 8,390,455 · App. 12/625,524 · Granted Mar 5, 2013

RF tag on test strips, test strip vials and boxes

Inventors: Timothy T. Goodnow (Pleasanton, CA); Lei (Lawrence) He (Moraga, CA)
Assignee: Abbott Diabetes Care Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,390,455
App. No.
12/625,524
Granted
Mar 5, 2013
Kind
B2
Abstract

A glucose monitoring system, includes a glucose sensor strip or package of strips. The strip includes a substrate and a glucose monitoring circuit that has electrodes and a bodily fluid application portion of selected chemical composition. An antenna is integrated with the glucose sensor strip. An RFID sensor chip is coupled with the glucose sensor strip and the antenna. The chip has a memory containing digitally-encoded data representing calibration and/or expiration date information for the strip.

Claims (32)

1. A radio frequency identification (RFID) device for processing analyte data, comprising:

a housing;

an output unit coupled to the housing for outputting information related to a monitored analyte level;

an antenna coupled to the housing; and

an RFID reader component coupled to the housing and the antenna, the RFID reader component configured to transmit a radio frequency (RF) signal and to detect a backscattering radio wave including digitally encoded data representing the analyte level monitored by an in vivo analyte sensor.

2. The device of claim 1 , wherein the antenna comprises one of a loop antenna or a dipole antenna.

3. The device of claim 2 , wherein the loop antenna comprises a conducting loop.

4. The device of claim 1 , wherein the housing includes a strip port.

5. The device of claim 1 , wherein the strip port is configured to receive an in vitro glucose test strip.

6. The device of claim 1 further including a memory coupled to the RFID reader component, the memory configured to store data representing one or more of a lot information associated with the analyte sensor, a calibration code associated with the analyte sensor, or an analyte sensor expiration information.

7. The device of claim 1 , wherein the RFID reader component detects the backscattering radio wave based on the transmitted RF signal.

8. The device of claim 7 , wherein the transmitted RF signal includes an RF power signal.

9. The device of claim 1 , wherein RFID reader component is configured to operate in an ultra high frequency (UHF) frequency band.

10. The device of claim 1 , wherein the output unit includes a display for displaying an indication related to the monitored analyte level.

11. The device of claim 10 , wherein the displayed indication includes a numerical value of the analyte level monitored by the analyte sensor.

12. The device of claim 1 , wherein the digitally encoded data representing the monitored analyte level includes a current analyte level data and one or more prior analyte level data detected by the analyte sensor.

13. A method, comprising:

coupling an output unit to a housing for outputting information related to a monitored analyte level;

coupling an antenna to the housing;

coupling a radio frequency identification (RFID) reader component to the housing and the antenna; and

transmitting a radio frequency (RF) signal from the RFID reader component and detecting a backscattering radio wave including digitally encoded data representing the analyte level monitored by an in vivo analyte sensor.

14. The method of claim 13 , wherein the antenna comprises one of a loop antenna or a dipole antenna.

15. The method of claim 14 , wherein the loop antenna comprises a conducting loop.

16. The method of claim 13 further including providing a strip port on the housing.

17. The method of claim 16 further including receiving an in vitro glucose test strip in the strip port.

18. The method of claim 13 further including coupling a memory to the RFID reader component and storing data representing one or more of a lot information associated with the analyte sensor, a calibration code associated with the analyte sensor, or an analyte sensor expiration information in the memory.

19. The method of claim 13 further including detecting the backscattering radio wave based on the transmitted RF signal by the RFID reader component.

20. The method of claim 19 , wherein the transmitted RF signal includes an RF power signal.

21. The method of claim 13 further including configuring the RFID reader component to operate in an ultra high frequency (UHF) frequency band.

22. The method of claim 13 including displaying an indication related to the monitored analyte level on the output unit.

23. The method of claim 22 , wherein the displayed indication includes a numerical value of the analyte level monitored by the analyte sensor.

24. The method of claim 13 , wherein the digitally encoded data representing the monitored analyte level includes a current analyte level data and one or more prior analyte level data detected by the analyte sensor.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2013
From: GOODNOW, TIMOTHY T.; HE, LAWRENCE
To: THERASENSE, INC.
Reel/Frame 029743/0481 →
CHANGE OF NAME Recorded Feb 2, 2013
From: THERASENSE, INC.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 029743/0503 →
Continuity (5)
Continuation 12476921 · Jun 2, 2009
Continuation 11350398 · Feb 7, 2006
Provisional Application 60650912 · Feb 8, 2005
Provisional Application 60701654 · Jul 21, 2005
Related Publication 20100152561A1 · Jun 17, 2010